Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Gamified Dual-Task Training for Balance and Exercise Enjoyment in Children With Spastic Cerebral Palsy

11. November 2026 aktualisiert von: Doç.Dr.Ömer Şevgin, Uskudar University

Effects of Low-Cost Gamified Motor-Cognitive Dual-Task Training on Balance and Exercise Enjoyment in Ambulatory Children and Adolescents With Spastic Cerebral Palsy Aged 11-17 Years: A Randomized Controlled Trial

This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.

Studienübersicht

Detaillierte Beschreibung

Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.

Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.

Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.

Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.

Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.

Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p < 0.05.

Studientyp

Interventionell

Einschreibung (Geschätzt)

60

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Güngören
      • Istanbul, Güngören, Türkei (türkiye)
        • Bizim Çocuklarımız SPECIAL EDUCATION AND REHABILITATION CENTER
        • Kontakt:
          • Amin Danesfhar

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

11 Jahre bis 17 Jahre (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Age 11-17 years
  • Diagnosis of spastic (unilateral or bilateral) cerebral palsy confirmed by a pediatric neurologist
  • Gross Motor Function Classification System (GMFCS) level I, II or III
  • Ability to walk independently for at least 10 meters with or without an assistive device
  • Ability to understand and follow two-step verbal commands
  • Receiving physiotherapy at the study center twice a week for at least 3 months
  • Written informed consent from the parent/legal guardian and written assent from the participant

Exclusion Criteria:

  • Botulinum toxin injection to the lower extremities within the last 6 months
  • Orthopedic surgery within the last 6 months
  • Uncontrolled epilepsy
  • Uncorrected visual or hearing impairment
  • Severe intellectual disability preventing performance of the cognitive tasks (counting, color discrimination)
  • Participation in another structured balance or exercise program during the study period
  • Uncontrolled cardiac or respiratory disease precluding exercise

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Gamified motor-cognitive dual-task training

Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment.

Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

Aktiver Komparator: Standard single-task balance training

Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Pediatric Balance Scale (PBS) score at 12 weeks
Zeitfenster: Week 12 (end of intervention)

The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy.

Week 12 (end of intervention)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Pediatric Balance Scale (PBS) score
Zeitfenster: Baseline, Week 12, Week 16 (4-week follow-up)

Same scale as the primary outcome; change from baseline.

Baseline, Week 12, Week 16 (4-week follow-up)
Timed Up and Go (TUG) test - single task
Zeitfenster: Baseline, Week 12, Week 16

Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility.

Baseline, Week 12, Week 16
Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)
Zeitfenster: Baseline, Week 12, Week 16

13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated.

Baseline, Week 12, Week 16
1-Minute Walk Test (1MWT)
Zeitfenster: Baseline, Week 12, Week 16

Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity.

Baseline, Week 12, Week 16
Physical Activity Enjoyment Scale (PACES-8, Turkish version)
Zeitfenster: Baseline, Week 12, Week 16

8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity.

Baseline, Week 12, Week 16

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienstuhl: Amin Danesfhar, Üsküdar University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

15. Dezember 2026

Primärer Abschluss (Geschätzt)

20. Februar 2027

Studienabschluss (Geschätzt)

20. Februar 2027

Studienanmeldedaten

Zuerst eingereicht

11. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. November 2026

Zuerst gepostet (Tatsächlich)

17. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Beschreibung des IPD-Plans

De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren